Routine Notice Added Final

CELL CULTURE METHOD

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 25th, 2026
Detected April 1st, 2026
Email

Summary

The European Patent Office published patent application EP4092101A1 for AJINOMOTO CO., INC., covering a cell culture method. The patent was published March 25, 2026, with inventors OGawa Shimpei, Higuchi Takuya, Furomitsu Shumpei, Nishiyama Megumi, and Koseki Kotoe. The application covers C12M 3/00, C12N 5/02, C12N 5/074, and C12N 5/10 classifications and is designated across all EPC contracting states.

What changed

The European Patent Office granted and published patent EP4092101A1 for a cell culture method developed by AJINOMOTO CO., INC. The patent covers methods under IPC classifications C12M 3/00, C12N 5/02, C12N 5/074, and C12N 5/10, with inventors OGawa Shimpei, Higuchi Takuya, Furomitsu Shumpei, Nishiyama Megumi, and Koseki Kotoe. The patent is designated across all European Patent Convention contracting states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.

Patent publications do not create compliance obligations. Third parties who believe this patent should not have been granted may file an opposition within nine months of publication. Competitors developing similar cell culture methods should review the patent claims to assess potential infringement risks. AJINOMOTO gains exclusive rights to the claimed cell culture technology across EPO member states.

Source document (simplified)

← EPO Patent Bulletin

CELL CULTURE METHOD

Publication EP4092101A1 Kind: A1 Mar 25, 2026

Applicants

AJINOMOTO CO., INC.

Inventors

OGAWA, Shimpei, HIGUCHI, Takuya, FUROMITSU, Shumpei, NISHIYAMA, Megumi, KOSEKI, Kotoe

IPC Classifications

C12M 3/00 20060101AFI20240131BHEP C12N 5/02 20060101ALI20240131BHEP C12N 5/074 20100101ALI20240131BHEP C12N 5/10 20060101ALI20240131BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

CELL CULTURE METHOD

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 25th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP4092101A1

Who this affects

Applies to
Pharmaceutical companies Manufacturers Investors
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Patent Grant
Geographic scope
European Union EU

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Biotechnology Pharmaceuticals

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.